Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-30 @ 1:28 PM
Study NCT ID:
NCT01634893
Status:
COMPLETED
Last Update Posted:
2016-03-25
First Post:
2012-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-03
First Submit QC Date:
None
Study First Post Date:
2012-07-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-24
Last Update Post Date:
2016-03-25
Last Update Post Date Type:
ESTIMATED